Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

6.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Cancer Prevention02:59

Cancer Prevention

2.6K
2.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Active surveillance of low-grade prostate cancer using the SurACaP Criteria: A multi-institutional series with a median follow-up of 10years.

The French journal of urology·2024
Same author

Good outcome of liver transplantation in patients with pre-existing renal cell carcinoma.

Clinics and research in hepatology and gastroenterology·2023
Same author

Active surveillance in favorable intermediate-risk prostate cancer: A single-center experience.

The French journal of urology·2023
Same author

Mid-term oncologic outcomes of radical prostatectomy in lymph node metastatic prostate cancer patients.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

Saline bladder infusion vs standard catheter removal in patients with acute urinary retention related to benign prostatic hyperplasia: The BLAPERF Study.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

[Urethroplasties for male urethral strictures: Success rates and predictive factors].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022

Related Experiment Video

Updated: May 3, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.5K

[CCAFU Recommendations 2013: Prostate cancer].

L Salomon, C Bastide, P Beuzeboc

  • 1Membre de la SFRO.

Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|February 4, 2014
PubMed
Summary

Updated prostate cancer guidelines emphasize early diagnosis and risk-specific treatments. Active surveillance for low-risk tumors and new hormonal therapies offer improved patient care pathways.

Keywords:
Cancer de la prostateDiagnosisDiagnosticGuidelinesProstate cancerRecommandationsTraitementTreatment

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

1.1K
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

2.1K

Related Experiment Videos

Last Updated: May 3, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.5K
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

1.1K
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

2.1K

Area of Science:

  • Urology
  • Oncology

Context:

  • The CCAFU prostate subcommittee established initial guidelines for prostate cancer care in 2010.
  • These guidelines required updating to reflect advancements in diagnosis and treatment.

Purpose:

  • To update the 2010 prostate cancer guidelines based on a systematic literature review.
  • To provide current standards of care for prostate cancer diagnosis, treatment, and evaluation.

Summary:

  • Updated guidelines incorporate specific pathological examination criteria (Gleason score) and establish prostate/pelvis MRI as the reference radiological exam.
  • Early diagnosis, the role of Prostate-Specific Antigen (PSA), and active surveillance for low-risk tumors are defined.
  • Treatment options include radical prostatectomy for all risk groups, refined hormonotherapy protocols (duration, metastatic vs. non-metastatic, intermittent use), and new therapeutic pathways with novel hormonal and bone-targeting drugs.

Impact:

  • The updated guidelines provide precise, individualized treatment strategies for various prostate cancer clinical situations.
  • These revisions reflect progress in prospective studies and novel therapeutics, enhancing the standard of care.
  • Future research directions include defining multidisciplinary treatments for high-risk tumors and optimizing adjuvant and sequential hormonal therapies.